Absolute Bioavailability of Reslizumab in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objective of this study is to assess the absolute bioavailability of reslizumab following administration of a single subcutaneous (sc) dose to healthy non-Japanese participants
Epistemonikos ID: 3a7abb64a1638b69a931076d8d1184c2d050503e
First added on: May 11, 2024